Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact firstname.lastname@example.org.
Lessons After the Early Management of the COVID-19 Outbreak in a Pediatric Transplant and Hemato-Oncology Center Embedded within a COVID-19 Dedicated Hospital in Lombardia, Italy. Estote Parati. (Be Ready.)
12 Pages Posted: 2 Apr 2020More...
Italy is the second exposed Country worldwide, after China, and Lombardia is the most affected Region in Italy, with more than half of the National cases, with 13% of whom being healthcare professionals.
The Clinica Pediatrica Università degli Studi di Milano Bicocca is a General Pediatric and Hematology Oncology and Transplant Center embedded within the designated COVID-19 general Hospital San Gerardo in Monza, located in Lombardia, Italy.
Preventive and control measures specifically undertaken to cope with the emergency within Hemato-Oncology, Transplant, and Outpatient Unit in the Pediatric Department have been described. Preliminary COVID-19 experiences with the first Italian pediatric hemato-oncology patients are reported. The few available data regarding pediatrics and specifically hemato-oncological patients are discussed.
The purpose of this report is to share pediatric hemato-oncology issues encountered in the first few weeks of the COVID-19 outbreak in Italy and to alert healthcare professionals worldwide to be prepared accordingly.
Funding Statement: No funding.
Declaration of Interests: The authors declare no competing interests.
Keywords: SARS-CoV-2; COVID-19; pediatric; hematology-oncology; transplantation
Suggested Citation: Suggested Citation